{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:17:37Z","timestamp":1784269057276,"version":"3.55.0"},"reference-count":46,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n The 2025 American College of Cardiology\/American Heart Association (ACC\/AHA) blood pressure (BP) guideline introduced new hypertension criteria. However, the association between newly defined nocturnal stage 1 hypertension (nocturnal BP 110-120\/65-70 mm Hg) and kidney function progression in the population not receiving dialysis with chronic kidney disease (CKD) in China remains unclear.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To determine whether nocturnal stage 1 hypertension as defined by 2025 ACC\/AHA guidelines in patients with CKD is associated with kidney function progression.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n A retrospective cohort study involving patients with CKD not receiving dialysis was conducted in China at the Third Affiliated Hospital of Sun Yat-sen University from August 2010 to December 2017 and at the Fifth Affiliated Hospital of Sun Yat-sen University from November 2017 to December 2024.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Participants were categorized into 3 groups based on nocturnal BP measurements according to the 2025 ACC\/AHA guidelines: nonhypertension (nocturnal BP &amp;lt;110\/65 mm Hg), stage 1 hypertension (nocturnal BP 110-120\/65-70 mm Hg), and stage 2 hypertension (nocturnal BP \u2265120\/70 mm Hg).<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was a composite of kidney failure requiring replacement therapy (KFRT) and worsening kidney function (WKF). Secondary outcomes included the individual components of the primary outcome. Cox regression models were employed to assess the association between nocturnal stage 1 hypertension and outcomes.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among 2418 participants with CKD stage 1 through 4 not receiving dialysis included in the study, 1412 (58.4%) were men, the mean (SD) age was 45.4 (14.4) years, 436 (18.0%) had nocturnal nonhypertension, 345 (14.3%) had nocturnal stage 1 hypertension, and 1637 (67.7%) had nocturnal stage 2 hypertension. Over a median (IQR) follow-up of 3.9 (1.5-4.7) years, 394 composite kidney outcomes, 203 cases of KFRT, and 235 instances of WKF were recorded. After adjusting for confounders, nocturnal stage 1 hypertension (compared with nocturnal nonhypertension) was independently associated with an increased risk of KFRT (hazard ratio [HR], 2.37; 95% CI, 1.17-4.82), WKF (HR, 3.79; 95% CI, 1.04-13.84), and the composite kidney outcome (HR, 2.49; 95% CI, 1.31-4.72). In the older population (aged \u226565 years), nocturnal BP less than 110\/65 mm Hg was associated with a higher risk of WKF and the composite kidney outcome compared with nocturnal BP in the range of 110\/65 to 120\/70 mm Hg.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cohort study of adults with CKD not receiving dialysis, nocturnal stage 1 hypertension as defined by the 2025 ACC\/AHA guidelines was independently associated with an increased risk of CKD progression.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.54035","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:00:52Z","timestamp":1768406452000},"page":"e2554035","source":"Crossref","is-referenced-by-count":1,"title":["Nocturnal Stage 1 Hypertension Defined by 2025 Guidelines in Adults With Chronic Kidney Disease"],"prefix":"10.1001","volume":"9","author":[{"given":"Ting","family":"Zhang","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, the Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China"},{"name":"Guangdong Provincial Engineering Research Center of Molecular Imaging, the Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengping","family":"Zhou","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, the Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China"},{"name":"Guangdong Provincial Engineering Research Center of Molecular Imaging, the Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, the Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China"},{"name":"Guangdong Provincial Engineering Research Center of Molecular Imaging, the Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Cai","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, the Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, the Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Peng","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, the Third Affiliated Hospital Sun Yat-sen University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, the Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China"},{"name":"Guangdong Provincial Engineering Research Center of Molecular Imaging, the Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, the Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China"},{"name":"Guangdong Provincial Engineering Research Center of Molecular Imaging, the Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Jiang","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, the Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China"},{"name":"Guangdong Provincial Engineering Research Center of Molecular Imaging, the Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"5","key":"zoi251438r1","doi-asserted-by":"publisher","first-page":"e307","DOI":"10.1016\/S2214-109X(16)00071-1","article-title":"Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study.","volume":"4","author":"Ene-Iordache","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"4","key":"zoi251438r2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/jamainternmed.2022.6817","article-title":"Prevalence of chronic kidney disease in China: results from the sixth China chronic disease and risk factor surveillance.","volume":"183","author":"Wang","year":"2023","journal-title":"JAMA Intern Med"},{"issue":"8","key":"zoi251438r3","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/CIRCRESAHA.122.321762","article-title":"Hypertension as cardiovascular risk factor in chronic kidney disease.","volume":"132","author":"Burnier","year":"2023","journal-title":"Circ Res"},{"issue":"1","key":"zoi251438r4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1053\/j.ajkd.2018.12.044","article-title":"Hypertension in CKD: core curriculum 2019.","volume":"74","author":"Ku","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"zoi251438r5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ekir.2016.05.001","article-title":"Ambulatory blood pressure in chronic kidney disease: ready for prime time?","volume":"1","author":"Velasquez","year":"2016","journal-title":"Kidney Int Rep"},{"issue":"3S","key":"zoi251438r6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","article-title":"KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease.","volume":"99","author":"Cheung","year":"2021","journal-title":"Kidney Int"},{"issue":"10393","key":"zoi251438r7","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/S0140-6736(23)00733-X","article-title":"Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59?124 patients.","volume":"401","author":"Staplin","year":"2023","journal-title":"Lancet"},{"issue":"10","key":"zoi251438r8","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/jch.12589","article-title":"Nocturnal hypertension correlates better with target organ damage in patients with chronic kidney disease than a nondipping pattern.","volume":"17","author":"Wang","year":"2015","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"6","key":"zoi251438r9","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1161\/HYPERTENSIONAHA.118.10971","article-title":"Nocturnal hypertension: new technology and evidence.","volume":"71","author":"Kario","year":"2018","journal-title":"Hypertension"},{"issue":"22","key":"zoi251438r10","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control.","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"issue":"18","key":"zoi251438r11","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.jacc.2025.05.007","article-title":"2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"86","author":"Jones","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"zoi251438r12","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.117.032380","article-title":"Status of hypertension in China: results from the China hypertension survey, 2012-2015.","volume":"137","author":"Wang","year":"2018","journal-title":"Circulation"},{"issue":"10","key":"zoi251438r13","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1177\/2047487318768938","article-title":"Population impact of the 2017 ACC\/AHA guidelines compared with the 2013 ESH\/ESC guidelines for hypertension management.","volume":"25","author":"Vaucher","year":"2018","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"zoi251438r14","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1161\/CIRCULATIONAHA.117.032890","article-title":"Global impact of 2017 American College of Cardiology\/American Heart Association hypertension guidelines: a perspective from China.","volume":"137","author":"Wang","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"zoi251438r15","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"24","key":"zoi251438r16","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1097\/CM9.0000000000003431","article-title":"Clinical practice guideline for the management of hypertension in China.","volume":"137","author":"Chinese Society of Cardiology, Chinese Medical Association; Hypertension Committee of Cross-Straits Medicine Exchange Association; Cardiovascular Disease Prevention and Rehabilitation Committee, Chinese Association of Rehabilitation Medicine","year":"2024","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"zoi251438r17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/ndt\/gfy301","article-title":"Applying the new intensive blood pressure categories to a nondialysis chronic kidney disease population: the prevalence, awareness and treatment rates in chronic kidney disease patients with hypertension in China survey.","volume":"35","author":"Zheng","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"zoi251438r18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s40292-020-00387-w","article-title":"Hypertension prevalence in Colombian patients evaluated with ambulatory blood pressure monitoring according to changes in clinical guidelines between 2017-2018.","volume":"27","author":"Giraldo-Gonzalez","year":"2020","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"11","key":"zoi251438r19","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.jacc.2018.06.056","article-title":"Long-term cardiovascular risk associated with stage 1 hypertension defined by the 2017 ACC\/AHA hypertension guideline.","volume":"72","author":"Qi","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"zoi251438r20","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1001\/jama.2018.13551","article-title":"Association of blood pressure classification in young adults using the 2017 American College of Cardiology\/American Heart Association blood pressure guideline with cardiovascular events later in life.","volume":"320","author":"Yano","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"zoi251438r21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1177\/2047487319862066","article-title":"Associations of blood pressure categories defined by 2017 ACC\/AHA guidelines with mortality in China: pooled results from three prospective cohorts.","volume":"27","author":"Liu","year":"2020","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"zoi251438r22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1161\/HYPERTENSIONAHA.119.14239","article-title":"Blood pressure classification of 2017 associated with cardiovascular disease and mortality in young Chinese adults.","volume":"76","author":"Wu","year":"2020","journal-title":"Hypertension"},{"issue":"23","key":"zoi251438r23","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1161\/CIRCULATIONAHA.120.052624","article-title":"Association of blood pressure classification using the 2017 American College of Cardiology\/American Heart Association blood pressure guideline with risk of heart failure and atrial fibrillation.","volume":"143","author":"Kaneko","year":"2021","journal-title":"Circulation"},{"issue":"14","key":"zoi251438r24","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1093\/eurjpc\/zwac193","article-title":"Reduction in blood pressure for elevated blood pressure\/stage 1 hypertension according to the American College of Cardiology\/American Heart Association guideline and cardiovascular outcomes.","volume":"29","author":"Kaneko","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"zoi251438r25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/CM9.0000000000002669","article-title":"Association of stage 1 hypertension defined by the 2017 ACC\/AHA guideline with cardiovascular events and mortality in Chinese adults.","volume":"137","author":"Gao","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"zoi251438r26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.amjcard.2021.12.023","article-title":"Risk for proteinuria in newly defined hypertensive people based on the 2017 American College of Cardiology\/American Heart Association blood pressure guideline.","volume":"168","author":"Suzuki","year":"2022","journal-title":"Am J Cardiol"},{"issue":"12","key":"zoi251438r27","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41371-019-0198-7","article-title":"Usefulness of the blood pressure classification in the new 2017 ACC\/AHA hypertension guidelines for the prediction of new-onset chronic kidney disease.","volume":"33","author":"Maeda","year":"2019","journal-title":"J Hum Hypertens"},{"issue":"7","key":"zoi251438r28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019764","article-title":"Chronic kidney disease risk of isolated systolic or diastolic hypertension in young adults: a nationwide sample based-cohort study.","volume":"10","author":"Bae","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"zoi251438r29","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1681\/ASN.2020081156","article-title":"BP in young adults with CKD and associations with cardiovascular events and decline in kidney function.","volume":"32","author":"Kula","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"13","key":"zoi251438r30","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease.","volume":"330","author":"Klahr","year":"1994","journal-title":"N Engl J Med"},{"issue":"19","key":"zoi251438r31","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"issue":"9463","key":"zoi251438r32","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial.","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"issue":"9","key":"zoi251438r33","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1681\/ASN.2017020148","article-title":"Effects of intensive BP control in CKD.","volume":"28","author":"Cheung","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"zoi251438r34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/j.ajkd.2022.04.010","article-title":"Dipping status, ambulatory blood pressure control, cardiovascular disease, and kidney disease progression: a multicenter cohort study of CKD.","volume":"81","author":"Borrelli","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"zoi251438r35","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41371-023-00884-0","article-title":"Prognostic utility of rhythmic components in 24-h ambulatory blood pressure monitoring for the risk stratification of chronic kidney disease patients with cardiovascular co-morbidity.","volume":"38","author":"El Jamal","year":"2024","journal-title":"J Hum Hypertens"},{"issue":"5","key":"zoi251438r36","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.14460","article-title":"Association of nighttime masked uncontrolled hypertension with left ventricular hypertrophy and kidney function among patients with chronic kidney disease not receiving dialysis.","volume":"5","author":"Fu","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi251438r37","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41440-024-02080-0","article-title":"Prognostic value of nighttime blood pressure in patients with chronic kidney disease.","volume":"48","author":"Li","year":"2025","journal-title":"Hypertens Res"},{"issue":"19","key":"zoi251438r38","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines.","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"zoi251438r39","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1097\/HJH.0000000000002930","article-title":"Lower ambulatory nocturnal SBP is associated with less cardiovascular and renal damage in normotensive hospitalized patients with chronic kidney disease.","volume":"39","author":"Zhang","year":"2021","journal-title":"J Hypertens"},{"issue":"4","key":"zoi251438r40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004223","article-title":"The association between antihypertensive treatment and serious adverse events by age and frailty: a cohort study.","volume":"20","author":"Sheppard","year":"2023","journal-title":"PLoS Med"},{"issue":"3","key":"zoi251438r41","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/ageing\/afz006","article-title":"Association of blood pressure with clinical outcomes in older adults with chronic kidney disease.","volume":"48","author":"Masoli","year":"2019","journal-title":"Age Ageing"},{"issue":"14","key":"zoi251438r42","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","article-title":"Trial of intensive blood-pressure control in older patients with hypertension.","volume":"385","author":"Zhang","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi251438r43","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1111\/jch.13907","article-title":"The contribution of the systolic and diastolic components for the diagnosis of arterial hypertension under the 2017 ACC\/AHA guideline and metabolic heterogeneity among individuals with Stage 1 hypertension.","volume":"22","author":"Cesena","year":"2020","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"2","key":"zoi251438r44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/HJH.0000000000003325","article-title":"Isolated systolic or diastolic hypertension and mortality risk in young adults using the 2017 American College of Cardiology\/American Heart Association blood pressure guideline: a longitudinal cohort study.","volume":"41","author":"Bo","year":"2023","journal-title":"J Hypertens"},{"issue":"4","key":"zoi251438r45","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1001\/jama.2019.21402","article-title":"Association of isolated diastolic hypertension as defined by the 2017 ACC\/AHA blood pressure guideline with incident cardiovascular outcomes.","volume":"323","author":"McEvoy","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"zoi251438r46","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2215\/CJN.14420920","article-title":"Nocturnal systolic hypertension and adverse prognosis in patients with CKD.","volume":"16","author":"Wang","year":"2021","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2843875\/zhang_2026_oi_251438_1767812640.67263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:00:53Z","timestamp":1768406453000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2843875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.54035","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]}}}